Published in Prog Immunobiol Stand on January 01, 1967
Quantitative in vitro measurement of simian virus 40 tumor-specific antigens. Proc Natl Acad Sci U S A (1971) 0.84
Interactions of human cytomegalovirus with human fibroblasts. J Bacteriol (1966) 2.00
Thymidine-kinase in cytomegalovirus infected cells. Arch Virol (1976) 1.96
Temperature-sensitive mutants of herpes simplex virus. Virology (1970) 1.83
Correlation between infectivity and physical virus particles in human cytomegalovirus. J Bacteriol (1966) 1.71
Thermoinactivation of human cytomegalovirus. J Bacteriol (1966) 1.56
Studies on production of biologically active substances which inhibit cell migration in supernatants and extracts of hypersensitive lymphoid cells incubated with specific antigen in vitro. Immunology (1968) 1.44
Human cytomegalovirus: properties of the complement-fixing antigen. J Immunol (1966) 1.44
Antibodies in human sera to soluble and viral antigens found in Burkitt lymphoma and other lymphoblastoid cell lines. J Natl Cancer Inst (1970) 1.43
WHO collaborative studies on poliovirus type 3 strains isolated during the 1968 poliomyelitis epidemic in Poland. Bull World Health Organ (1972) 1.42
Ribonucleotides linked to DNA of herpes simplex virus type 1. J Virol (1974) 1.28
Papovaviridae. Intervirology (1974) 1.26
Prospective study on the relationship between cervical neoplasia and herpes simplex type-2 virus. II. Herpes simplex type-2 antibody presence in sera taken at enrollment. Int J Cancer (1984) 1.14
Association of some supraglottic laryngeal carcinomas with EB virus. Int J Cancer (1983) 1.07
Activation of peripheral lymphocytes in the course of experimental allergic encephalomyelitis in the guinea-pig. Z Immunitatsforsch Exp Klin Immunol (1972) 1.06
Studies on the growth of herpes simplex virus in lymphoblastoid cells. Acta Virol (1971) 1.06
Increased oncogenicity and synthesis of herpesvirus antigens in hamster cells exposed to herpes simplex type-2 virus. J Natl Cancer Inst (1973) 1.05
Sero-epidemiology of the Epstein-Barr virus: preliminary analysis of an international study - a review. IARC Sci Publ (1975) 1.03
Demonstration of specific induction of erythrocytes phagocytosis by macrophates from normal, non-sensitized rabbits by a factor released from lymph node cells of immunized rabbits. Experientia (1968) 1.03
Replicating DNA of herpes simplex virus type 1. Intervirology (1976) 1.03
XXY son of XX-XXX mother. Lancet (1972) 1.01
Studies on the mechanism of delayed type hypersensitivity in tissue culture. VII. An attempt to demonstrate the mediated action of antigen on cells from hypersensitive animals by means of simultaneous cultivation of two fragments in one chamber. Z Immunitatsforsch Allerg Klin Immunol (1967) 1.00
Presence of Epstein-Barr virus DNA in carcinomas of the palatine tonsil. J Natl Cancer Inst (1984) 1.00
Demonstration of migration inhibiting substances in sera of guinea pigs with delayed type hypersensitivity to ovalbumin influenced with systemic antigen administration. Z Immunitatsforsch Allerg Klin Immunol (1969) 0.98
Modified HPV16 E7 Genes as DNA Vaccine against E7-Containing Oncogenic Cells. Virology (2001) 0.98
Relationship between Epstein-Barr virus-determined complement-fixing antigen and nuclear antigen detected by anticomplement fluorescence. J Natl Cancer Inst (1974) 0.97
Vitamin C-induced increase of dermatan sulfate in cultured Hurler's fibroblasts. Science (1966) 0.97
Further characterization of antigen-dependent migration inhibition factor in mice. Immunology (1975) 0.96
Role of mediators of cellular hypersensitivity in the stimulation of the antibody formation to unrelated antigen. Cell Immunol (1973) 0.95
Study of the Hurler syndrome using cell culture: definition of the biochemical phenotype and the effects of ascorbic acid on the mutant cell. J Clin Invest (1968) 0.93
Activation of the peripheral lymphocytes in the course of the immune response to transplanted SV40-transformed tumour cells in hamsters. Immunology (1974) 0.92
Absence of cytomegalovirus DNA from adenocarcinoma of the colon. Intervirology (1980) 0.92
Sweat pore counts in ectodermal dysplasias. Hum Genet (1981) 0.92
Longitudinal follow-up of antibody response to selected antigens of human papillomaviruses and herpesviruses in patients with invasive cervical carcinoma. Int J Cancer (2000) 0.91
HLA and obesity. Biomed Pharmacother (1984) 0.91
Studies on the mechanism of delayed type hypersensitivity in tissue cultures. V. The influence of the specific antigen concentration upon the spleen cell migration in normal and sensitized guinea-pigs. Z Immunitatsforsch Allerg Klin Immunol (1966) 0.91
The use of an in vitro test of delayed type hypersensitivity for the detection of specific tumor antigen of transplantation type induced by SV 40 virus. Z Immunitatsforsch Allerg Klin Immunol (1968) 0.91
Studies on the mechanism of delayed type hypersensitivity in tissue cultures. XIV. Species nonspecificity of biologically active substances (migration inhibiting factor) released during the interaction of hypersensitive lymphocytes with antigen in vitro. Z Immunitatsforsch Allerg Klin Immunol (1971) 0.91
Replication of cytomegalovirus in human epitheloid diploid cell line. Arch Virol (1976) 0.90
Mapping of serologically relevant regions of human cytomegalovirus phosphoprotein pp150 using synthetic peptides. J Gen Virol (1991) 0.90
Demonstration of the inflammatory activity of the supernatant of hypersensitive lymph node cells incubated with a high dose of antigen. Immunology (1969) 0.89
Human papillomavirus genotype spectrum in Czech women: correlation of HPV DNA presence with antibodies against HPV-16, 18, and 33 virus-like particles. J Med Virol (1999) 0.89
Phosphonylmethyl ethers of acyclic nucleoside analogues: inhibitors of HSV-1 induced ribonucleotide reductase. Antiviral Res (1990) 0.89
Lymphocyte nucleoli activation as a marker of autoimmune disorder development. I. Observation in NZB mice. Immunology (1976) 0.88
Comparison of genetic properties of influenza viruses before and after repeated passages in monkey kidney cell culture. Acta Virol (1968) 0.88
Absence of cytomegalovirus, Epstein-Barr virus, and papillomavirus DNA from adenoma and adenocarcinoma of the colon. Acta Virol (1988) 0.88
Studies on the mechanism of delayed type hypersensitivity in tissue culture. X. The ability of substances released during cultivation of hypersensitive spleen cells with antigen to influence migration activity of normal cells. Z Immunitatsforsch Allerg Klin Immunol (1967) 0.87
Determination of herpes simplex virus type-specific antibodies by solid-phase RIA on Helix pomatia lectin-purified antigens. J Infect Dis (1984) 0.87
Preparation of antisera against the S antigen of influenza A virus by immunization of guinea pigs with internal S antigen. Arch Gesamte Virusforsch (1967) 0.87
Comparison of ELISA and western blotting for human papillomavirus type 16 E7 antibody determination. J Gen Virol (1991) 0.87
Effects of n-butyrate and phorbol ester (TPA) on induction of Epstein-Barr virus antigens and cell differentiation. Arch Virol (1984) 0.87
Prospective study on the relationship between cervical neoplasia and herpes simplex type-2 virus. I. Epidemiological characteristics. Int J Cancer (1984) 0.86
Spontaneous delayed hypersensitivity to DNA in NZB mice. Immunology (1974) 0.86
Synthetic peptides derived from E7 region of human papillomavirus type 16 used as antigens in ELISA. J Gen Virol (1990) 0.86
Properties of a new type 3 attenuated poliovirus. VI. Alimentary tract resistance in children fed previously with type 3 Sabin vaccine to reinfection with homologous and heterologous type 3 attenuated poliovirus. Arch Gesamte Virusforsch (1967) 0.86
Chemical properties of antigen-dependent migration inhibition factor in mice. Immunology (1976) 0.86
In vitro studies of cell-mediated immunity in rabbits sensitized with Mycobacterium kansasii and Mycobacterium tuberculosis. Folia Microbiol (Praha) (1980) 0.86
Variation in neurovirulence of NWS influenza virus after repeated passages in different tissue culture systems. I. Derivation and neurotropic activity of NWS virus lines. Arch Gesamte Virusforsch (1968) 0.86
A new type 3 attenuated poliovirus for possible use in oral poliovirus vaccine. Prog Med Virol (1967) 0.85
Multiplicity reactivation in UV-irradiated herpes simplex type 1 virus. Intervirology (1973) 0.85
Human papillomavirus infection and cervical carcinoma. Clin Obstet Gynecol (2000) 0.85
Studies on the mechanism of delayed type hypersensitivity in tissue cultures. IX. The effect of glucose concentration on the reaction of delayed type hypersensitivity in tissue cultures. Z Immunitatsforsch Allerg Klin Immunol (1967) 0.85
Cellular immunity in patients with tuberculosis caused by Mycobacterium kansasii and Mycobacterium tuberculosis. J Hyg Epidemiol Microbiol Immunol (1979) 0.85
Serological response to HPV16 in CIN-III and cervical cancer patients. Case-control studies in Spain and Colombia. Int J Cancer (1996) 0.85
Linkage between reproductive capacity at increased temperature and neurotropic activity in A-NWS HONi (HON1) influenza virus. Infect Immun (1974) 0.84
Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancer. J Clin Oncol (1997) 0.84
Genetic determination of tuberculin hypersensitivity in chicken inbred lines. Eur J Immunol (1974) 0.84
Biochemical analysis of epiphyseal cartilage during growth and in some osteochondrodysplasias. Birth Defects Orig Artic Ser (1975) 0.83
Properties of a new type 3 attenuated poliovirus. V. Neurovirulence tests in monkeys after a passage through the human alimentary tract. Arch Gesamte Virusforsch (1965) 0.83
Presence of Epstein-Barr virus DNA in tonsillar tissues. Acta Virol (1981) 0.83
Plaque formation by NWS influenza virus in a human diploid cell strain. Acta Virol (1967) 0.83
Antibodies to EB virus capsid antigen and to soluble antigen of lymphoblastoid cells in infectious mononucleosis patients. Int J Cancer (1972) 0.83
Herpes simplex type 2 virus and cervical neoplasia. Adv Cancer Res (1987) 0.83
Effect of 3-beta-hydroxysteroid dehydrogenase gene deletion on virulence and immunogenicity of different vaccinia viruses and their recombinants. Arch Virol (1998) 0.83
Prevalence of antibodies to human papillomaviruses in the general population of the Czech Republic. Int J Cancer (1998) 0.83
Search for optimal parent for recombinant vaccinia virus vaccines. Study of three vaccinia virus vaccinal strains and several virus lines derived from them. Vaccine (1995) 0.83
Metastatic MHC class I-negative mouse cells derived by transformation with human papillomavirus type 16. Br J Cancer (2001) 0.82
Some properties of the soluble (S) antigen of cultured lymphoblastoid cell lines. Arch Gesamte Virusforsch (1970) 0.82
Interleukin 2 gene therapy of residual disease in mice carrying tumours induced by HPV 16. Int J Oncol (1999) 0.82